Europe’s largest cannabis trade show and fair, Spannabis, has announced that its March 2025 event
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors,
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van
Researchers from Brazil have published a detailed study showing significant improvements in a patient living
A recent YouGov poll, asking the British public their views on cannabis reform compared to
At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban
The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD
The legal dispensing of cannabis via a cultivation association has taken place for the first
Six years on from the legalisation of medical cannabis in the UK, families have made
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re
A study has found that a single high dose of psilocybin can lead to physical
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the
The number of items prescribed in the UK’s private medical cannabis market has doubled each
Product Earth, the UK’s largest event celebrating cannabis and other natural medicines, has cancelled the
Landlords, property managers, and housing associations in the UK are currently at risk of breaching
Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to
Introduction: The Life of a CAPEX Director As the Director of Capital Projects (CAPEX) for investors based in Geneva, my professional journey took me to Africa, South Asia, and the Middle East. My work involved extensive travel to various “hot spots,” which left me returning home to England only when possible. This lifestyle eventually took […]
The post From CAPEX Director to Cannabis Advocate: A Journey of Resilience and Healing appeared first on I Am Billy.
In what was thought to be a first for a major mainstream health conference on
In a new series, Cannabis Health News talks to people who have experienced emigration in search of safe, legal cannabis access. Read last week’s story here Previous stories have focused on the difficulty of packing your entire life into boxes and emigrating with your family to a new
A survey of cancer survivors from across the USA has shown that nearly half reported using cannabis at some point in their lifetimes and that the most popular form of delivery is via smoking joints. The survey, which was published in the journal Cancers included 1886
Recent studies add to the growing evidence base to support the use of cannabis in Tourette’s syndrome, PTSD, Parkinson’s and as a tool for chronic pain. With a record number of research papers published on cannabis and its therapeutic potential in 2022, it can be hard
Cannabis products high in CBD can ease anxiety better than THC-dominant products, new research suggests. A study of 300 people, published in the journal Cannabis and Cannabinoid Research, is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms. The study, led
In this “Flower-Side Chats” series of articles, Green interviews integrated cannabis companies and flower brands that are bringing unique business models to the industry. Particular attention is focused on how these businesses integrate innovative practices to navigate a rapidly changing landscape of regulations, supply chain and
On the 1st of November 2018, the UK government moved cannabis from Schedule 1 to Schedule 2 of the Misuse of Drugs Act 1971. While this might sound like a small change, this rescheduling actually allowed the medical prescription of cannabis-based products in the UK for
A team of researchers from University College London (UCL) have begun a clinical trial exploring the potential of DMT to treat alcohol use disorder. The study aims to enhance treatment options for individuals seeking to reduce or eliminate their alcohol consumption, and “to better understand how
The Czech Republic has put forward a draft bill for a regulated cannabis market that would allow individuals to buy up to 5 grams of cannabis per day for recreational purposes. Under the plans, people who wish to use cannabis recreationally would need to register in
CBD Guru is a UK based CBD brand that has been producing quality products since its launch in 2018. We recently caught up with the founder, Neil Mumby, to learn how a friend’s illness took him on a personal journey to create a range of CBD
A report published this week by The National Centre for Social Research (NatCen) has found that 80% of Generation Z support the legalisation of cannabis in the United Kingdom. The report, titled Society Watch 2024: Understanding the new generation of voters, provides insight into three key policy issues
The Deputy Prime Minister of Thailand, Anutin Charnvirakul, has announced the country will now regulate cannabis through legislation rather than re-listing it as a narcotic, marking a swift U-turn from plans to re-criminalise the drug. Thailand decriminalised cannabis in 2022 by removing it from a list
The cannabis world is packed full of widely shared beliefs and strange myths – many of which the origin has now faded into obscurity. Take, for example, the persistent rumour that George Washington was a fully-fledged stoner, getting high on his own supply from his hemp
The ten participants of Eaze’s 2021 Momentum incubator pitched their business ideas to major investors. The post Eaze’s 2021 accelerator class shows budding genius appeared first on Leafly.
In this “Flower-Side Chats” series of articles, Green interviews integrated cannabis companies and flower brands that are bringing unique business models to the industry. Particular attention is focused on how these businesses integrate innovative practices in order to navigate a rapidly changing landscape of regulatory, supply
CBDA – the precursor to CBD – is often dismissed as an inactive compound, but its benefits may be under-appreciated, writes Laurence Brown of BROWN’s CBD. Sponsored Out of the hundreds of biologically active compounds produced by the hemp plant, CBD is certainly the star of
Germany could be set to scale back its plans for the nationwide legalisation of adult-use cannabis in favour of a ‘more realistic’ approach to reform – but what will this look like? There has been much hype and speculation around Germany’s plans to legalise adult-use cannabis,
Legalising and regulating the sale of cannabis would have significant health, societal and economic benefits for the UK, writes medicinal cannabis patient, Adam Reilly*. Cannabis is a highly-debated drug that has cultivated public interest and controversy for decades. While cannabis has been used recreationally and medicinally
KANABO announced the launch of two new additions to its range of VapePod formulas this week, in what is expected to be the first in a flurry of announcements due in the coming months. The launch of two new high-THC formulas, which represent the second generation
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to
Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients
As medical cannabis products have gained increasing attention throughout the world, and particularly in the UK, perhaps one of the most discussed areas of research is that of the potential of cannabinoids in Epilepsy treatments. In 2018, the government rescheduled cannabis following in response to evidence
We asked our team why they enjoyed working at Sapphire and what helping patients safely access medical cannabis means to them. Meet the team and find out more via About Us… The post Meet The Team appeared first on Sapphire Medical Clinics.
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
